Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS)
机构:[1]Department of Medical Oncology, Cancer Hospital and Institute,Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China[2]Peking University Cancer Hospital, Beijing, China[3]Henan cancer hospital, Henan, China河南省肿瘤医院[4]The 2nd hospital of Dalian Medical University, Dalian, China[5]Department of haematological oncology, cancer hospital of Shanxi province, taiyuan, China[6]Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China[7]The First Hospital of Jilin University, Jilin, China[8]The Fourth Military Medical University, Xi'an, China[9]Liaoning Cancer Hospital and Institute, Shenyang, China[10]Department of Lymphoma, Sino-US Center for Lymphoma and Leukemia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China[11]The Fourth Hospital of Hebei Medical University, Shijiazhuang, China河北医科大学第四医院[12]Department of Lymphoma, 307 Hospital of PLA, Beijing, China[13]307 hospital of PLA, Beijing, China[14]Jilin Cancer Hospital, Changchun, China[15]General Hospital of Ningxia Medical University, Yinchuan, China[16]Peking University First Hospital, Beijing, China[17]Xinjiang Cancer Hospital, Wulumuqi, China[18]The general hospital of Chinese People's Liberation Army, Beijing, China[19]The people's hospital of Tangshan City, Tangshan, China[20]Baotou Cancer Hospital, Baotou, China[21]The 3rd Hospital of Haerbin Medical University, Ha'erbin, China[22]Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China临床科室血液内科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[23]Taishan Medical University, Tai'an, China
第一作者机构:[1]Department of Medical Oncology, Cancer Hospital and Institute,Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
推荐引用方式(GB/T 7714):
Hu Shaoxuan,Song Yuqin,Li Yufu,et al.Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS)[J].BLOOD.2016,128(22):doi:10.1182/blood.V128.22.4228.4228.
APA:
Hu, Shaoxuan,Song, Yuqin,Li, Yufu,Sun, Xiuhua,Su, Liping...&He, Xiaohui.(2016).Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS).BLOOD,128,(22)
MLA:
Hu, Shaoxuan,et al."Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS)".BLOOD 128..22(2016)